U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Morphine Sulfate Injection
Status: Currently in Shortage
»Date first posted: 10/31/2017
»Therapeutic Categories: Analgesia/Addiction

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 02/06/2025)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) Available

Fresenius Kabi USA, LLC (Revised 02/13/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) Unavailable Backordered. Next release not available at this time. Check wholesaler for inventory. Demand increase for the drug
Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) Available Check wholesalers for inventory
Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) Unavailable Not available at this time. Demand increase for the drug
Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) Unavailable Backordered. Next release not available at this time. Check wholesaler for inventory. Demand increase for the drug
Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) Available Check wholesalers for inventory
Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 02/14/2025)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) Available Currently available. Additional product will be made available as it is released.
Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Revised 01/27/2025)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) Unavailable Next Delivery: May 2025; Estimated Recovery: June 2025 Other
Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) Unavailable Next Delivery and Estimated Recovery: March 2025 Other
Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01) Unavailable Next Delivery and Estimated Recovery: December 2028 Other
Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) Available
Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) Available
Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) Limited Availability Limited Supply Available. Next Delivery: February 2025; Estimated Recovery: March 2025 Other
Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) Unavailable Next Delivery: April 2025; Estimated Recovery: June 2025 Other
Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05) Unavailable Next Delivery and Estimated Recovery: December 2027 Other

Piramal Critical Care Inc. (Reverified 01/14/2025)

Company Contact Information:
800-414-1901

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Mitigo (Morphine Sulfate Injection, USP), Injection, 200 mg/20 mL (NDC 66794-160-02) Available
Mitigo (Morphine Sulfate Injection, USP), Injection, 500 mg/20 mL (NDC 66794-162-02) Available
Back to Top